Press
He
Weizmann Wonder Wander
Science news and culture
Search
echo t('Click') ?>
X
Menu
Home Page
Area of Research
Math & Computer Science
People
Space & Physics
Chemistry
Life Sciences
Environment
Science Teaching
Scientific Archaeology
Technology & Applications
The Campus
The Website
For Journalists
RSS Service
Subscribe to our monthly newsletter/press releases
He
Skip to Home
Skip to Search
Skip to Content
Skip to Contact us
Skip to Sitemap
Skip to Accessibility Statement
Press Releases
All Press Releases
Receive Press Releases
RSS
News
Top Stories
Subscribe to our Monthly Newsletter
Explore Topics
Math and Computer Science
Space and Physics
Chemistry
Life Sciences
Environment
More
Scientific Archaeology
Science Teaching
Technology & Applications
People and Events
Awards and Appointments
People
Events
Science on Tap
Conferences
On Campus
Art on Campus
All People and Events
Multimedia
The Beauty of Science
Videos and Lectures
Nano Comics
Around Campus
More
Publications
Special Issues
Blue Sky Research
Planting Knowledge
100 Milestones in Physics
Art on Campus
All Special Issues
Buildings on Campus
What the Tree Has
Weizmann International Magazine of Science and People
About
About the Weizmann Institute of Science
Facts and Figures
Dr. Chaim Weizmann
Visit the Weizmann Institute of Science
Follow Us
Are you a journalist?
Please sign up here for our press releases
Subscribe to our monthly newsletter:
First name
Last name
Email
*
Agreement
*
I agree to the
Terms of Use
and
Cookie & Privacy Policy
You are here
Home
>
Topics
>
Technology & Applications
> Yeda Technology Transfer
Yeda Technology Transfer
Technology & Applications
Yeda Technology Transfer
Benefiting Humanity
Biotechnology
Diagnostic Techniques and Drugs
Spiking the Particle
25.04.2022
Viruses & Microorganisms
,
Disease, Drugs & Diagnostics
,
Technology & Applications
,
Yeda Technology Transfer
,
Benefiting Humanity
,
Biotechnology
,
Diagnostic Techniques and Drugs
FDA approves third-generation hepatitis B vaccine based on Weizmann research
The Meat, the Muscle, and the Motion of Cell Fusion
20.12.2021
Nutrition
,
Stem Cells
,
Molecular and Cell Biology
,
Technology & Applications
,
Yeda Technology Transfer
,
Biotechnology
Revelations about muscle stem cell fusion find their way into the food tech industry
Catching on to Cancer
28.11.2021
Structural Biology
,
Cancer
,
Molecular and Cell Biology
,
Disease, Drugs & Diagnostics
,
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
A particularly “sticky” molecule could lead to the development of an effective treatment for cancer
Our Customers Want Yellow Bananas
04.03.2021
Yeda Technology Transfer
,
Benefiting Humanity
An interview with the CEO of Yeda, Dr. Opher Shapira, who took office in the midst of a pandemic and radical changes in the global economy
Yeda News
01.10.2020
Disease, Drugs & Diagnostics
,
Yeda Technology Transfer
,
Biotechnology
,
Diagnostic Techniques and Drugs
Gene Therapy Firm Enters Collaboration Agreement with Weizmann Lab
A Faster Path from the Lab Bench to the Clinic
20.05.2020
Yeda Technology Transfer
,
Benefiting Humanity
,
Diagnostic Techniques and Drugs
Orchard Innovations is a new joint venture that aims to advance the translation of scientific discovery to the healthcare market
The Israel Institute for Biological Research and the Weizmann Institute of Science Collaborate to Fight Coronavirus
06.05.2020
Immunology
,
Disease, Drugs & Diagnostics
,
Yeda Technology Transfer
,
Benefiting Humanity
,
Biotechnology
,
Diagnostic Techniques and Drugs
A milestone in relations between the two institutes could advance a cure
All Natural Color
15.07.2019
Biochemistry
,
Plants and Agriculture
,
Yeda Technology Transfer
Phytolon, a start-up based on Weizmann Institute technology, aims to replace artificial food dyes with safe, cost-effective, stable, all-natural...
TOOKAD®, Invented at the Weizmann Institute of Science, Gains European Approval for Prostate Cancer
29.04.2019
Biochemistry
,
Cancer
,
Personalized Medicine
,
Disease, Drugs & Diagnostics
,
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
The treatment, approved for use in 31 countries, is now being marketed in Germany, Italy, Israel and Mexico
South Korea Invests in Weizmann Institute of Science Biomed
19.03.2019
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
Two Korean concerns will invest 12 million dollars in companies based on Institute research
Pages
1
2
3
4
5
next ›
last »
Top Stories
See All >
Curbing Candida: The Cells That Keep Fungal Infections at Bay
"Set Your Goals as High as Possible – and Perhaps Even Higher"
Scent of a Friend
Dr. Ruth Scherz-Shouval
Press Releases
See All >
27.06.2022
Curbing Candida: The Cells That Keep Fungal Infections at Bay
24.06.2022
Scent of a Friend
13.06.2022
The Heat Is On: Weizmann Institute Scientists Uncover Traces of Fire Dating Back At Least 800,000 Years
Accessibility Toolbar
❌
+
Enlarge text
-
Reduce text
Monochrome
Contrast
Underline Links
Reset
Accessibility Statement